Ambra1 deficiency impairs mitophagy in skeletal muscle.


Journal

Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883

Informations de publication

Date de publication:
08 2022
Historique:
revised: 21 03 2022
received: 05 01 2022
accepted: 14 04 2022
pubmed: 21 5 2022
medline: 26 8 2022
entrez: 20 5 2022
Statut: ppublish

Résumé

Maintaining healthy mitochondria is mandatory for muscle viability and function. An essential surveillance mechanism targeting defective and harmful mitochondria to degradation is the selective form of autophagy called mitophagy. Ambra1 is a multifaceted protein with well-known autophagic and mitophagic functions. However, the study of its role in adult tissues has been extremely limited due to the embryonic lethality caused by full-body Ambra1 deficiency. To establish the role of Ambra1 as a positive regulator of mitophagy, we exploited in vivo overexpression of a mitochondria-targeted form of Ambra1 in skeletal muscle. To dissect the consequence of Ambra1 inactivation in skeletal muscle, we generated muscle-specific Ambra1 knockout (Ambra1 Our data show that Ambra1 has a critical role in the mitophagic flux of adult murine skeletal muscle and that its genetic inactivation leads to mitochondria alterations and myofibre remodelling. Ambra1 overexpression in wild-type muscles is sufficient to enhance mitochondria clearance through the autophagy-lysosome system. Consistently with this, Ambra1-deficient muscles display an abnormal accumulation of the mitochondrial marker TOMM20 by +76% (n = 6-7; P < 0.05), a higher presence of myofibres with swollen mitochondria by +173% (n = 4; P < 0.05), and an alteration in the maintenance of the mitochondrial membrane potential and a 34% reduction in the mitochondrial respiratory complex I activity (n = 4; P < 0.05). Lack of Ambra1 in skeletal muscle leads to impaired mitophagic flux, without affecting the bulk autophagic process. This is due to a significantly decreased recruitment of DRP1 (n = 6-7 mice; P < 0.01) and Parkin (n = 6-7 mice; P < 0.05) to the mitochondrial compartment, when compared with controls. Ambra1-deficient muscles also show a marked dysregulation of the endolysosome compartment, as the incidence of myofibres with lysosomal accumulation is 20 times higher than wild-type muscles (n = 4; P < 0.05). Histologically, Ambra1-deficient muscles of both 3- and 6-month-old animals display a significant decrease of myofibre cross-sectional area and a 52% reduction in oxidative fibres (n = 6-7; P < 0.05), thus highlighting a role for Ambra1 in the proper structure and activity of skeletal muscle. Our study indicates that Ambra1 is critical for skeletal muscle mitophagy and for the proper maintenance of functional mitochondria.

Sections du résumé

BACKGROUND
Maintaining healthy mitochondria is mandatory for muscle viability and function. An essential surveillance mechanism targeting defective and harmful mitochondria to degradation is the selective form of autophagy called mitophagy. Ambra1 is a multifaceted protein with well-known autophagic and mitophagic functions. However, the study of its role in adult tissues has been extremely limited due to the embryonic lethality caused by full-body Ambra1 deficiency.
METHODS
To establish the role of Ambra1 as a positive regulator of mitophagy, we exploited in vivo overexpression of a mitochondria-targeted form of Ambra1 in skeletal muscle. To dissect the consequence of Ambra1 inactivation in skeletal muscle, we generated muscle-specific Ambra1 knockout (Ambra1
RESULTS
Our data show that Ambra1 has a critical role in the mitophagic flux of adult murine skeletal muscle and that its genetic inactivation leads to mitochondria alterations and myofibre remodelling. Ambra1 overexpression in wild-type muscles is sufficient to enhance mitochondria clearance through the autophagy-lysosome system. Consistently with this, Ambra1-deficient muscles display an abnormal accumulation of the mitochondrial marker TOMM20 by +76% (n = 6-7; P < 0.05), a higher presence of myofibres with swollen mitochondria by +173% (n = 4; P < 0.05), and an alteration in the maintenance of the mitochondrial membrane potential and a 34% reduction in the mitochondrial respiratory complex I activity (n = 4; P < 0.05). Lack of Ambra1 in skeletal muscle leads to impaired mitophagic flux, without affecting the bulk autophagic process. This is due to a significantly decreased recruitment of DRP1 (n = 6-7 mice; P < 0.01) and Parkin (n = 6-7 mice; P < 0.05) to the mitochondrial compartment, when compared with controls. Ambra1-deficient muscles also show a marked dysregulation of the endolysosome compartment, as the incidence of myofibres with lysosomal accumulation is 20 times higher than wild-type muscles (n = 4; P < 0.05). Histologically, Ambra1-deficient muscles of both 3- and 6-month-old animals display a significant decrease of myofibre cross-sectional area and a 52% reduction in oxidative fibres (n = 6-7; P < 0.05), thus highlighting a role for Ambra1 in the proper structure and activity of skeletal muscle.
CONCLUSIONS
Our study indicates that Ambra1 is critical for skeletal muscle mitophagy and for the proper maintenance of functional mitochondria.

Identifiants

pubmed: 35593053
doi: 10.1002/jcsm.13010
pmc: PMC9434724
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Ambra1 protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2211-2224

Subventions

Organisme : Telethon Foundation
ID : GGP14202
Organisme : Telethon Foundation
ID : GGP19229
Organisme : Italian Ministry of University and Research
ID : 2015FBNB5Y
Organisme : Italian Ministry of University and Research
ID : 201742SBXA
Organisme : AFM-Telethon trampoline
ID : AFM-18376
Organisme : Cariparo Foundation University of Padova

Informations de copyright

© 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.

Références

Nat Commun. 2019 Jun 12;10(1):2576
pubmed: 31189900
J Physiol. 2018 Jul;596(13):2565-2579
pubmed: 29682760
Nat Rev Mol Cell Biol. 2020 Apr;21(4):204-224
pubmed: 32071438
Biochim Biophys Acta Rev Cancer. 2018 Dec;1870(2):137-150
pubmed: 30059724
J Biol Chem. 2011 Apr 1;286(13):11649-58
pubmed: 21292769
EMBO Mol Med. 2013 Jun;5(6):870-90
pubmed: 23630012
J Cell Sci. 2012 Feb 15;125(Pt 4):795-9
pubmed: 22448035
J Physiol. 2017 Oct 15;595(20):6391-6399
pubmed: 28795394
Cold Spring Harb Perspect Biol. 2013 May 01;5(5):a011387
pubmed: 23580791
J Cell Biol. 2008 Dec 1;183(5):795-803
pubmed: 19029340
Acta Neuropathol. 2021 Sep;142(3):537-564
pubmed: 34302498
EMBO J. 2016 Aug 1;35(15):1677-93
pubmed: 27334614
Cell Death Dis. 2012 Nov 15;3:e418
pubmed: 23152054
Cell Death Differ. 2020 Apr;27(4):1155-1168
pubmed: 31434979
J Cachexia Sarcopenia Muscle. 2019 Jun;10(3):630-642
pubmed: 30895728
PLoS One. 2014 Jun 12;9(6):e99210
pubmed: 24922546
Front Physiol. 2016 Jan 12;6:422
pubmed: 26793123
Nature. 2007 Jun 28;447(7148):1121-5
pubmed: 17589504
J Cell Sci. 2015 Jun 1;128(11):2003-8
pubmed: 26034061
Cell Metab. 2009 Dec;10(6):507-15
pubmed: 19945408
Nat Cell Biol. 2018 Jul;20(7):745-754
pubmed: 29950572
J Cachexia Sarcopenia Muscle. 2022 Aug;13(4):2211-2224
pubmed: 35593053
Nat Commun. 2021 May 5;12(1):2550
pubmed: 33953176
Skelet Muscle. 2015 Mar 18;5:9
pubmed: 25834726
Genes Dev. 2007 Nov 15;21(22):2861-73
pubmed: 18006683
J Cell Biol. 2010 Oct 4;191(1):155-68
pubmed: 20921139
Mol Cell Oncol. 2015 Feb 24;2(1):e970059
pubmed: 27308402
Front Pharmacol. 2019 Oct 10;10:1193
pubmed: 31649547
J Neurosci. 2011 Jul 13;31(28):10249-61
pubmed: 21753002
Sci Transl Med. 2021 Apr 7;13(588):
pubmed: 33827972
Front Physiol. 2021 Mar 25;12:638983
pubmed: 33841177
Autophagy. 2010 Nov;6(8):1078-89
pubmed: 20861693
Hum Mol Genet. 2008 Dec 15;17(24):3897-908
pubmed: 18782848
Autophagy. 2019 Sep;15(9):1674-1676
pubmed: 31234693
Cell Metab. 2007 Dec;6(6):458-71
pubmed: 18054315
Zebrafish. 2020 Apr 22;:
pubmed: 32320344
Nature. 2021 Apr;592(7856):799-803
pubmed: 33854232
Cell. 2012 Mar 16;148(6):1145-59
pubmed: 22424226
Cell Mol Life Sci. 2021 Feb;78(4):1305-1328
pubmed: 33078210
Cell Death Differ. 2015 Mar;22(3):419-32
pubmed: 25215947
Nat Med. 2010 Nov;16(11):1313-20
pubmed: 21037586

Auteurs

Lisa Gambarotto (L)

Department of Molecular Medicine, University of Padova, Padova, Italy.
Department of Biology, University of Padova, Padova, Italy.

Samuele Metti (S)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Martina Chrisam (M)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Cristina Cerqua (C)

Institute of Pediatric Research IRP, Fondazione Città della Speranza, Padova, Italy.

Patrizia Sabatelli (P)

IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
CNR - Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza", Unit of Bologna, Bologna, Italy.

Andrea Armani (A)

Department of Biomedical Sciences, University of Padova, Padova, Italy.
Fondazione per la Ricerca Biomedica Avanzata, VIMM, Padova, Italy.

Carlo Zanon (C)

Institute of Pediatric Research IRP, Fondazione Città della Speranza, Padova, Italy.

Marianna Spizzotin (M)

Department of Biology, University of Padova, Padova, Italy.

Silvia Castagnaro (S)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Flavie Strappazzon (F)

IRCCS Fondazione Santa Lucia, Rome, Italy.
Institut NeuroMyogène, CNRS UMR5261 - INSERM U1315, Université Claude Bernard Lyon 1, Lyon, France.

Paolo Grumati (P)

Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.

Matilde Cescon (M)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Paola Braghetta (P)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Eva Trevisson (E)

Institute of Pediatric Research IRP, Fondazione Città della Speranza, Padova, Italy.
Clinical Genetics Unit, Department of Women's and Children's Health, University of Padova, Padova, Italy.

Francesco Cecconi (F)

Danish Cancer Society Research Center, Copenhagen, Denmark.

Paolo Bonaldo (P)

Department of Molecular Medicine, University of Padova, Padova, Italy.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH